UA128952C2 - Фармацевтична композиція, яка включає поверхневі і нуклеокапсидні антигени вірусу гепатиту в - Google Patents

Фармацевтична композиція, яка включає поверхневі і нуклеокапсидні антигени вірусу гепатиту в Download PDF

Info

Publication number
UA128952C2
UA128952C2 UAA201810715A UAA201810715A UA128952C2 UA 128952 C2 UA128952 C2 UA 128952C2 UA A201810715 A UAA201810715 A UA A201810715A UA A201810715 A UAA201810715 A UA A201810715A UA 128952 C2 UA128952 C2 UA 128952C2
Authority
UA
Ukraine
Prior art keywords
antigen
hepatitis
hbsad
virus
hbv
Prior art date
Application number
UAA201810715A
Other languages
English (en)
Ukrainian (uk)
Inventor
Рубідо Хуліо Сесар Агілар
РУБИДО Хулио Сесар АГИЛАР
Мато Ядіра Лобайна
МАТО Ядира ЛОБАЙНА
Перес Енріке Іглесіас
Перес Енрике Иглесиас
Аріас Едуардо Пентон
АРИАС Эдуардо ПЕНТОН
Ньєто Херардо Енріке Гільєн
Ньето Херардо Энрике Гильнн
Сантіаго Хорхе Агустін Агіар
Сантиаго Хорхе Агустин Агиар
БЛАНКО Сонья ГОНСАЛЕС
Ернандес Хорхе Вальдес
Эрнандес Хорхе Вальдес
Кастільо Маріела Васкес
Кастильо Мариела Васкес
Original Assignee
Сентро Де Інхеньєрія Хенетіка І Біотекнолохія
Сентро Дэ Инхеньерия Хенетика И Биотекнолохия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сентро Де Інхеньєрія Хенетіка І Біотекнолохія, Сентро Дэ Инхеньерия Хенетика И Биотекнолохия filed Critical Сентро Де Інхеньєрія Хенетіка І Біотекнолохія
Publication of UA128952C2 publication Critical patent/UA128952C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
UAA201810715A 2016-03-31 2017-03-14 Фармацевтична композиція, яка включає поверхневі і нуклеокапсидні антигени вірусу гепатиту в UA128952C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CU2017/050001 WO2017167317A1 (es) 2016-03-31 2017-03-14 Composición farmacéutica que comprende los antígenos de la superficie y de la nucleocápsida del virus de la hepatitis b
CU2016000038A CU24454B1 (es) 2016-03-31 2017-03-14 Composición farmacéutica que comprende los antígenos de la superficie y de la nucleocápsida del virus de la hepatitis b

Publications (1)

Publication Number Publication Date
UA128952C2 true UA128952C2 (uk) 2024-12-11

Family

ID=58671308

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201810715A UA128952C2 (uk) 2016-03-31 2017-03-14 Фармацевтична композиція, яка включає поверхневі і нуклеокапсидні антигени вірусу гепатиту в

Country Status (16)

Country Link
US (2) US11491218B2 (OSRAM)
EP (1) EP3437654B1 (OSRAM)
JP (1) JP6981992B2 (OSRAM)
KR (1) KR20180125985A (OSRAM)
CN (1) CN109219449B (OSRAM)
AR (1) AR108009A1 (OSRAM)
AU (1) AU2017243136B2 (OSRAM)
CU (1) CU24454B1 (OSRAM)
EA (1) EA201892212A1 (OSRAM)
ES (1) ES2965709T3 (OSRAM)
MX (1) MX2018011793A (OSRAM)
MY (1) MY202118A (OSRAM)
TW (1) TWI755383B (OSRAM)
UA (1) UA128952C2 (OSRAM)
WO (1) WO2017167317A1 (OSRAM)
ZA (1) ZA201806325B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4034158A4 (en) * 2019-09-23 2023-10-04 Ascendo Biotechnology, Inc. BIODEGRADABLE NANOCOMPLEX VACCINE, METHODS FOR SUPPRESSING HEPATITIS B VIRUS REPLICATION AND SECRETION OF HEPATITIS B VIRUS SURFACE ANTIGEN
EP4087858A1 (en) 2020-01-10 2022-11-16 Carogen Corporation Compositions and methods of use of oncolytic virus like vesicles
CU20200028A7 (es) 2020-04-20 2021-11-04 Ct Ingenieria Genetica Biotecnologia Nucleoproteína viral y formulaciones que la contienen
JP2025506732A (ja) * 2022-02-22 2025-03-13 カロジェン コーポレイション 感染症およびがんの免疫療法適用のための多用途のウイルス様小胞（ｖｌｖ）プラットフォーム
CN116218881B (zh) * 2022-10-21 2024-08-13 山东大学 一种治疗或者预防乙肝病毒的疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22290A1 (es) 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
CU22871A1 (es) 1998-12-02 2003-10-21 Ct Ingenieria Genetica Biotech Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
CU23002A1 (es) * 2000-12-01 2004-11-18 Ct Ingenieria Genetica Biotech Método de obtención de agregados antigénicos y su uso en formulaciones
CN1164331C (zh) * 2001-05-23 2004-09-01 中国人民解放军第二军医大学 一种人乙型肝炎核酸疫苗
CU23740A1 (es) * 2009-09-29 2011-12-28 Ct Ingenieria Genetica Biotech Método de obtención de una formulación de antígenos del virus de la hepatitis b
CN104338132A (zh) * 2013-07-26 2015-02-11 复旦大学 一种病毒免疫治疗药物复合物及其用途

Also Published As

Publication number Publication date
EA201892212A1 (ru) 2019-03-29
BR112018069738A2 (pt) 2019-02-05
JP6981992B2 (ja) 2021-12-17
TW201735945A (zh) 2017-10-16
JP2019510064A (ja) 2019-04-11
HK1259329A1 (zh) 2019-11-29
EP3437654A1 (en) 2019-02-06
CU20160038A7 (es) 2017-11-07
ES2965709T3 (es) 2024-04-16
US11759517B2 (en) 2023-09-19
EP3437654B1 (en) 2023-09-20
MX2018011793A (es) 2018-12-17
MY202118A (en) 2024-04-04
US20200297840A1 (en) 2020-09-24
US20220193228A1 (en) 2022-06-23
KR20180125985A (ko) 2018-11-26
AU2017243136A1 (en) 2018-10-11
US11491218B2 (en) 2022-11-08
TWI755383B (zh) 2022-02-21
CN109219449A (zh) 2019-01-15
CN109219449B (zh) 2022-08-30
AR108009A1 (es) 2018-07-04
CA3017778A1 (en) 2017-10-05
ZA201806325B (en) 2020-08-26
CU24454B1 (es) 2019-11-04
WO2017167317A1 (es) 2017-10-05
AU2017243136B2 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
US11759517B2 (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus
CN110996999A (zh) 包含插入有脂肽的脂质体作为有效成分的疫苗佐剂及其用途
JP2021506767A (ja) Ｂ型肝炎免疫化レジメン及び組成物
EP0946200A1 (en) Immunization of infants
JP2021506771A (ja) Ｂ型肝炎免疫化レジメン及び組成物
US12128100B2 (en) Immunogenic compositions for treatment of Hepatitis B
US11771759B2 (en) Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use
JP2007511585A (ja) アルキルホスファチジルコリン配合ワクチン組成物
US20120308615A1 (en) Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization
RU2362586C2 (ru) Фармацевтические композиции для терапевтического применения
CA3017778C (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus
EA040981B1 (ru) Фармацевтическая композиция, которая включает поверхностные и нуклеокапсидные антигены вируса гепатита b
HK1259329B (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus
US20220288187A1 (en) Biodegradable nanocomplex vaccines, methods for suppression of hepapitis b virus replication and hepapitis b virus surface antigen secretion
WO2025226656A1 (en) Hepatitis b virus mrna vaccines
BR112018069738B1 (pt) Composição farmacêutica, e, uso da mesma
Guillén et al. Desarrollo de plataforma de adyuvación para vacunas preventivas y terapeúticas basada en partículas semejantes a virus: demostración de efecto en modelos animales y humanos
HK1097761A (en) Pharmaceutical compositions for therapeutic use